As of 2026-09-12, the Fair Value of Regenxbio Inc (RGNX) is -15.52 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.56 USD, the upside of Regenxbio Inc is -281.29%.
With the market price of 8.56 USD and our fair value calculation, Regenxbio Inc (RGNX) is not a good investment. Investing in RGNX stocks now will result in a potential loss of 281.29%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 127.80 | -280.30 | -263.49 | -227.10 | -193.88 | -167.39 |
| YoY growth | 214.82% | -319.33% | 6.00% | 13.81% | 14.63% | -14.01% |
| Market Cap (mil) | 541.76 |
| P/E | |
| Forward P/E |
| EPS | -3.10 |
| Avg earnings growth rate | -14.01% |
| TTM earnings | -196.43 |